VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025)
VitaNova Life Sciences (VNOV) posted Cash from Financing Activities of -$101500.0 for Q2 2025, down 283.02% on a QoQ basis from -$26500.0 in Q1 2025, and down 320.55% year-over-year from $46021.1 in Q2 2024.
VitaNova Life Sciences (VNOV) Cash from Financing Activities (2017 - 2025) Analysis & Trends
VitaNova Life Sciences' Cash from Financing Activities history runs 8 years deep, the most recent figure standing at -$101500.0 for Q2 2025.
- Quarterly Cash from Financing Activities fell 320.55% year-over-year to -$101500.0 in Q2 2025, while the trailing twelve-month figure through Jan 2026 was -$101500.0 (down 236.49% YoY) and the FY2025 annual result came in at -$3000.0, down 100.31% from the prior year.
- Cash from Financing Activities was -$101500.0 for Q2 2025 at VitaNova Life Sciences, down from -$26500.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $958913.0 in Q1 2024 and bottomed at -$101500.0 in Q2 2025.
- A 4-year average of $82662.1 and a median of $9853.0 in 2021 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 23872.82% — and 2025, when it sank 320.55%.
- VitaNova Life Sciences' Cash from Financing Activities stood at $12100.0 in 2021, then plunged by 33.96% to $7991.0 in 2023, then jumped by 806.02% to $72400.0 in 2024, then plunged by 240.19% to -$101500.0 in 2025.
- Business Quant data shows VNOV's Cash from Financing Activities at -$101500.0 in Q2 2025, -$26500.0 in Q1 2025, and $72400.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | -2.82 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 3.98 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -483.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 120.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 3.80 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 51.08 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -1.37 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 347,627.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -101,500.00 |
| Apr 30, 2025 | -101,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Jan 31, 2025 | -26,500.00 |
| Oct 31, 2024 | 72,400.00 |
| Oct 31, 2024 | 72,400.00 |
| Jul 31, 2024 | 52,600.00 |
| Jul 31, 2024 | 52,600.00 |
| Apr 30, 2024 | -24,135.00 |
| Apr 30, 2024 | -24,135.00 |
| Jan 31, 2024 | 958,913.00 |
| Jan 31, 2024 | 958,913.00 |
| Oct 31, 2023 | 7,991.00 |
| Oct 31, 2023 | 7,991.00 |
| Jul 31, 2023 | 17,419.00 |
| Jul 31, 2023 | 17,419.00 |
| Jan 31, 2023 | 4,000.00 |
| Jan 31, 2023 | 4,000.00 |
| Oct 31, 2021 | 12,100.00 |
| Oct 31, 2021 | 12,100.00 |